Mitochondrial disorders
Gene: ATP5L2The rating of this gene has been updated from Amber to Red following NHS Genomic Medicine Service approval.Created: 29 Jul 2022, 1:47 p.m. | Last Modified: 29 Jul 2022, 1:47 p.m.
Panel Version: 2.109
Cannot find evidence for Mendelian gene-disease association.Created: 18 Mar 2020, 6:44 a.m. | Last Modified: 18 Mar 2020, 6:44 a.m.
Panel Version: 2.5
Added new-gene-name tag, new approved HGNC gene symbol for ATP5L2 is ATP5MGLCreated: 18 Dec 2019, 3:50 p.m. | Last Modified: 18 Dec 2019, 3:50 p.m.
Panel Version: 2.3
Initial gene list and info collated by Carl Fratter (Oxford University Hospitals NHS Trust) January 2019 on behalf of the GMS Mitochondrial specialist test group.Created: 23 Jul 2019, 10:13 a.m. | Last Modified: 23 Jul 2019, 10:13 a.m.
Panel Version: 1.412
Source Expert Review Red was added to ATP5L2. Rating Changed from Amber List (moderate evidence) to Red List (low evidence)
Tag new-gene-name tag was added to gene: ATP5L2.
gene: ATP5L2 was added gene: ATP5L2 was added to Mitochondrial disorders. Sources: NHS GMS,Expert Review Amber Mode of inheritance for gene: ATP5L2 was set to Unknown Phenotypes for gene: ATP5L2 were set to No OMIM phenotype